Science Explorer Back to mapMap
Discussion
Researcher · Qurient (South Korea) · South Korea

Hwankyu Kang

Hwankyu Kang publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Phagocytosis and Immune Regulation, Immune cells in cancer and Cancer therapeutics and mechanisms.

OpenAlex
World rank
#3,232,989
of 7,710,434 ranked researchers
Rank in South Korea
#48,636
of 162,609
Works
20
Citations
894
Citations per work
44.7
h-index
6
i10-index 6Top 93% in Immunology
Hwankyu Kang

What does Hwankyu Kang research?

Hwankyu Kang's work is mostly in Medicine (37%), Immunology and Microbiology (35%), Biochemistry, Genetics and Molecular Biology (14%).

Life Sciences: 10 works · 49.0% of their workImmunology and Microbiology: 7 works · 35.3% of their workImmunology: 7 works · 35.3% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 13.7% of their workMolecular Biology: 3 works · 13.7% of their workHealth Sciences: 7 works · 37.3% of their workMedicine: 7 works · 37.3% of their workOncology: 3 works · 15.7% of their workInfectious Diseases: 2 works · 11.8% of their workEpidemiology: 1 works · 5.9% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 3.9% of their workEverything else: 3 works · 13.7% of their workTHEIR WORKHwankyu Kang20works
Life Sciences49%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology735.3%
    2. Biochemistry, Genetics and Molecular Biology313.7%
    1. Medicine737.3%
  3. Everything else313.7%
  1. 1Immunology35% of their works
  2. 2Oncology16% of their works
  3. 3Molecular Biology14% of their works
  4. 4Infectious Diseases12% of their works
  5. 5Epidemiology6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Hwankyu Kang's research?

The keywords of their largest research topics: apoptotic cells, CD47, Chemotherapy, Activation, Diagnosis, Epidemiology, Macrophage and DNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. CD4791 topic
  2. Chemotherapy92 topics
  3. apoptotic cells91 topic
  4. Activation81 topic
  5. Diagnosis82 topics
  6. Epidemiology82 topics
  7. Macrophage81 topic
  8. DNA71 topic
  9. Topoisomerases71 topic
  10. Tumor Microenvironment62 topics
  11. Mycobacterium tuberculosis51 topic
  12. Tuberculosis51 topic
  13. Immune Checkpoint Blockade41 topic
  14. Immunotherapy42 topics
  15. PD-1 and PD-L141 topic
  16. Mycobacterium avium31 topic
  17. Nontuberculous Mycobacteria31 topic
  18. Bacterial Therapy21 topic
  19. Pancreatic Cancer21 topic
  20. Surgical Complications21 topic
  21. Tumor Targeting21 topic

Where does Hwankyu Kang work?

Hwankyu Kang's main affiliation in the publication record is Qurient (South Korea), South Korea.

How many publications and citations does Hwankyu Kang have?

OpenAlex counts 20 works and 894 citations for Hwankyu Kang, an h-index of 6, ranking #3,232,989 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hwankyu Kang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.